| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.03 | 0.8 |